Copper
Copper is an essential transition metal with broad biological and medical relevance.
Copper is an essential transition metal with broad biological and medical relevance. In living systems, copper exists in tightly regulated ionic forms, most notably Cu(I) and Cu(II), because unbound copper can participate in redox chemistry that influences oxidative stress, reactive oxygen species formation, and cellular signaling. This tight control is important for maintaining normal mitochondrial function, enzyme activity, and metal homeostasis, while copper imbalance can contribute to pathological states such as Wilson's disease and can also be exploited therapeutically in cancer biology.
In biomedical research, copper is increasingly studied not only as a trace element and diagnostic analyte, but also as a mechanistic driver of copper-dependent cell death, including cuproptosis. Recent work has focused on copper delivery, intracellular copper release, and copper-triggered mitochondrial proteotoxicity, particularly in tumor cells and the tumor microenvironment. Copper has also been combined with materials-based platforms, prodrugs, and photothermal or hydrogel systems to enhance targeted therapy, immune reprogramming, and controlled copper release in diseases such as cancer and metabolic liver disease.
Where the papers sit
27 papers from the last 6 months study copper directly · updated from PubMed 5 Nov 2026
Study type 1 clinical trial · 1 observational · 3 human data · 21 preclinical · 1 unclassified
Themes one subject · 1 new direction
Those 27 are all about one subject.
-
Copper Biology and Applications
Copper research spans tumor cuproptosis, infection control, inherited deficiency, neurodegeneration, metabolic disease, and engineered materials. Nanoparticles, MOFs, hydrogels, chelators, and nanoclusters recur as ways to deliver, sequester, or redirect copper. Cancer studies emphasize ATP7B efflux, FOSL1, lipid reprogramming, chemo-radiation synergy, and immune remodeling, while other work tests antimicrobial, anti-inflammatory, antidiabetic, and restorative effects. The cluster remains exploratory rather than converging on one clinical application, with efficacy, toxicity, targeting, and mechanism still open.
Copper nanoclusters become a brain-penetrant replacement therapy for inherited copper deficiency
Menkes disease in ATP7A-deficient Mo-blo mice was treated with copper nanoclusters rather than copper as a cytotoxic or pathway-modulating agent. Although copper-histidine therapy failed to restore brain function, the nanoclusters crossed the blood–brain barrier, normalized cuproprotein activity, improved survival, and restored cognitive and motor functions. This assigns copper a distinct role as a systemically delivered neurorestorative replacement for genetically driven cerebral copper deficiency, opening a therapeutic direction outside the set’s dominant uses in cancer killing, antimicrobial activity, chelation, redox modulation, and biomaterials 42814820Sep.
Papers
The 27 papers from the last 6 months that study copper directly, newest first, by theme and by study type. Study types come from PubMed publication types and MeSH headings.
By theme
Copper Biology and Applications (27)
- PMID 42127742
- A Golgi-Targeted Cu-MOF Nanoplatform Overcomes ATP7B-Mediated Copper Efflux to Amplify Chemo-Cuproptosis Synergy against Colorectal Cancer. Nano letters · 4 Nov 2026 PMID 42980555
- Harnessing chia seed polysaccharides for green synthesis of copper-based nanoparticles with antidiabetic and anti-inflammatory activities. PloS one · 30 Oct 2026 PMID 42961858
- Restoring brain functions in the Mo-blo mouse model of Menkes disease with copper nanoclusters. Science advances · 30 Sept 2026 PMID 42814820
- Metallotoxicity-driven oxidative perturbations in spinal cord injury: Unraveling the pathophysiological nexus between metal-induced redox imbalance and disease severity: A correlational and multivariate analysis. Molecular biology reports · 15 Sept 2026 PMID 42742870
- Prediction of the properties of sintered copper-graphite composites using response surface methodology. PloS one · 11 Sept 2026 PMID 42726785
- An Inhalable Hybrid Nitric Oxide Nanogenerator for Lung Adenocarcinoma Treatment via Bioorthogonal-Activated Gas-Immunotherapy. Journal of the American Chemical Society · 9 Sept 2026 PMID 42714559
- Metal-Ion-Mediated Amyloid- β Aggregation in Alzheimer's Disease: A Mathematical Model of Chelation and Inhibitory Therapies. Bulletin of mathematical biology · 21 Aug 2026 PMID 42624961
- TPEN, a Well-Known Zinc Chelator, Sequesters Attomolar-Buffered Cellular Cu(I) Through an Oxygen-Dependent Mechanism. ACS chemical neuroscience · 19 Aug 2026 PMID 42615641
- Targeting Activator Protein-1 Transcription Factor Subunit FOSL1-Mediated Cuproptosis Sensitizes Radioresistant Non-Small Cell Lung Cancer. ACS nano · 18 Aug 2026 PMID 42611215
- Solvent-Directed Assembly and Rheological Dynamics of Multistimuli-Responsive Mg(II) and Cu(II) Metallosupramolecular Flexible Nanoscaffolds for Biological Applications. The journal of physical chemistry. B · 13 Aug 2026 PMID 42593139
- Chirality-dependent antibacterial activity of copper-cysteine nanoparticles enables functional silk sutures for enhanced wound healing. Biomaterials science · 13 Aug 2026 PMID 42592816
- Multi-omics mechanistic studies for curcumin-mediated intracellular copper release to alleviate MAFLD. Naunyn-Schmiedeberg's archives of pharmacology · 12 Aug 2026 PMID 42584672
- Ultrasound-responsive metastable copper/zinc-polyphenol framework for targeted anti-infection of diabetic wounds. Journal of controlled release : official journal of the Controlled Release Society · 10 Aug 2026 PMID 42575213
- Metal Ion-Triggered Collapsed Hydrogels as Materials for Bacterial Population Control. ACS applied bio materials · 10 Aug 2026 PMID 42574693
- Silver and Copper Nanoparticles as Non-Antibiotic Therapy for Postpartum Endometritis in Dairy Cows. Veterinary medicine and science · 5 Aug 2026 PMID 42555560
- A copper nanoplatform with irreversible electroporation induces cuproptosis via lipid reprogramming and remodels tumor immunity in pancreatic cancer. Journal of controlled release : official journal of the Controlled Release Society · 26 Jul 2026 PMID 42503313
- An injectable thiolated alginate/oxidized dextran hydrogel with curcumin-copper nanoparticles for corneal neovascularization after alkali burn. Carbohydrate polymers · 23 Jul 2026 PMID 42493130
- Nilotinib induces immunogenic cuproptosis to potentiate cancer immunotherapy. Cell reports. Medicine · 22 Jul 2026 PMID 42486098
- Design of an activatable unimolecular multicargo prodrug to deliver diethyldithiocarbamate and copper for targeted ovarian cancer therapy. Chemical communications (Cambridge, England) · 21 Jul 2026 PMID 42478879
- Plasmonic trimer nanoarrays with probe-trapping sites for SERS detection of urinary copper in Wilson's disease. The Analyst · 10 Jul 2026 PMID 42429542
- Electric-Field-Driven Ferredoxin 1-Independent Cuproptosis Induction Overcomes Therapy-Induced Resistance in Glioblastoma. ACS nano · 7 Jul 2026 PMID 42411583
- Asymmetric hydrogel with "spear-shield" properties promotes diabetic foot ulcer healing by modulating macrophage autophagy. Journal of controlled release : official journal of the Controlled Release Society · 6 Jul 2026 PMID 42409241
- A Self-Monitoring Single-Atom Copper Nanocapsule for Cascade-Responsive Tumor Cuproptosis Therapy. Angewandte Chemie (International ed. in English) · 6 Jul 2026 PMID 42405495
- Injectable pH-responsive gelatin methacryloyl hydrogel for cuproptosis-synergized sunitinib therapy and immune reprogramming in clear cell renal cell carcinoma. Acta biomaterialia · 2 Jul 2026 PMID 42392517
- Photothermal Pulse Output-Nanomachines for Enhanced Cuproptosis in Tumor Cells. ACS applied bio materials · 30 Jun 2026 PMID 42378513
- Cu2+-selective porphyrin probes with multifunctional anti-AD activities and the structural-activity insights from X-ray single crystal analysis. European journal of medicinal chemistry · 13 Jun 2026 PMID 42288030
By study type
Clinical trials (1)
- Silver and Copper Nanoparticles as Non-Antibiotic Therapy for Postpartum Endometritis in Dairy Cows. Veterinary medicine and science · 5 Aug 2026 PMID 42555560
Observational studies and case reports (1)
- Metallotoxicity-driven oxidative perturbations in spinal cord injury: Unraveling the pathophysiological nexus between metal-induced redox imbalance and disease severity: A correlational and multivariate analysis. Molecular biology reports · 15 Sept 2026 PMID 42742870
Human data, design not indexed (3)
- Metal-Ion-Mediated Amyloid- β Aggregation in Alzheimer's Disease: A Mathematical Model of Chelation and Inhibitory Therapies. Bulletin of mathematical biology · 21 Aug 2026 PMID 42624961
- Plasmonic trimer nanoarrays with probe-trapping sites for SERS detection of urinary copper in Wilson's disease. The Analyst · 10 Jul 2026 PMID 42429542
- Photothermal Pulse Output-Nanomachines for Enhanced Cuproptosis in Tumor Cells. ACS applied bio materials · 30 Jun 2026 PMID 42378513
Preclinical: animal, cell and lab studies (21)
- A Golgi-Targeted Cu-MOF Nanoplatform Overcomes ATP7B-Mediated Copper Efflux to Amplify Chemo-Cuproptosis Synergy against Colorectal Cancer. Nano letters · 4 Nov 2026 PMID 42980555
- Harnessing chia seed polysaccharides for green synthesis of copper-based nanoparticles with antidiabetic and anti-inflammatory activities. PloS one · 30 Oct 2026 PMID 42961858
- Effervescent sensing tablets for clean handling and shake-free, rapid copper detection in water. The Analyst · 26 Oct 2026 PMID 42932188
- Restoring brain functions in the Mo-blo mouse model of Menkes disease with copper nanoclusters. Science advances · 30 Sept 2026 PMID 42814820
- Prediction of the properties of sintered copper-graphite composites using response surface methodology. PloS one · 11 Sept 2026 PMID 42726785
- An Inhalable Hybrid Nitric Oxide Nanogenerator for Lung Adenocarcinoma Treatment via Bioorthogonal-Activated Gas-Immunotherapy. Journal of the American Chemical Society · 9 Sept 2026 PMID 42714559
- TPEN, a Well-Known Zinc Chelator, Sequesters Attomolar-Buffered Cellular Cu(I) Through an Oxygen-Dependent Mechanism. ACS chemical neuroscience · 19 Aug 2026 PMID 42615641
- Targeting Activator Protein-1 Transcription Factor Subunit FOSL1-Mediated Cuproptosis Sensitizes Radioresistant Non-Small Cell Lung Cancer. ACS nano · 18 Aug 2026 PMID 42611215
- Solvent-Directed Assembly and Rheological Dynamics of Multistimuli-Responsive Mg(II) and Cu(II) Metallosupramolecular Flexible Nanoscaffolds for Biological Applications. The journal of physical chemistry. B · 13 Aug 2026 PMID 42593139
- Chirality-dependent antibacterial activity of copper-cysteine nanoparticles enables functional silk sutures for enhanced wound healing. Biomaterials science · 13 Aug 2026 PMID 42592816
- Ultrasound-responsive metastable copper/zinc-polyphenol framework for targeted anti-infection of diabetic wounds. Journal of controlled release : official journal of the Controlled Release Society · 10 Aug 2026 PMID 42575213
- Metal Ion-Triggered Collapsed Hydrogels as Materials for Bacterial Population Control. ACS applied bio materials · 10 Aug 2026 PMID 42574693
- A copper nanoplatform with irreversible electroporation induces cuproptosis via lipid reprogramming and remodels tumor immunity in pancreatic cancer. Journal of controlled release : official journal of the Controlled Release Society · 26 Jul 2026 PMID 42503313
- An injectable thiolated alginate/oxidized dextran hydrogel with curcumin-copper nanoparticles for corneal neovascularization after alkali burn. Carbohydrate polymers · 23 Jul 2026 PMID 42493130
- Nilotinib induces immunogenic cuproptosis to potentiate cancer immunotherapy. Cell reports. Medicine · 22 Jul 2026 PMID 42486098
- Design of an activatable unimolecular multicargo prodrug to deliver diethyldithiocarbamate and copper for targeted ovarian cancer therapy. Chemical communications (Cambridge, England) · 21 Jul 2026 PMID 42478879
- Electric-Field-Driven Ferredoxin 1-Independent Cuproptosis Induction Overcomes Therapy-Induced Resistance in Glioblastoma. ACS nano · 7 Jul 2026 PMID 42411583
- Asymmetric hydrogel with "spear-shield" properties promotes diabetic foot ulcer healing by modulating macrophage autophagy. Journal of controlled release : official journal of the Controlled Release Society · 6 Jul 2026 PMID 42409241
- A Self-Monitoring Single-Atom Copper Nanocapsule for Cascade-Responsive Tumor Cuproptosis Therapy. Angewandte Chemie (International ed. in English) · 6 Jul 2026 PMID 42405495
- Injectable pH-responsive gelatin methacryloyl hydrogel for cuproptosis-synergized sunitinib therapy and immune reprogramming in clear cell renal cell carcinoma. Acta biomaterialia · 2 Jul 2026 PMID 42392517
- Cu2+-selective porphyrin probes with multifunctional anti-AD activities and the structural-activity insights from X-ray single crystal analysis. European journal of medicinal chemistry · 13 Jun 2026 PMID 42288030
Unclassified: not yet indexed with MeSH (1)
- Multi-omics mechanistic studies for curcumin-mediated intracellular copper release to alleviate MAFLD. Naunyn-Schmiedeberg's archives of pharmacology · 12 Aug 2026 PMID 42584672
Written from 27 PubMed abstracts, each one listed by PMID above. Published: 2026-08-15. Last written: 2026-09-17 by GPT. Drafted by language models from published abstracts; not medical advice.